<html><head></head><body><h1>Latrix</h1><p class="drug-subtitle"><b>Generic Name:</b> urea<br/>
<b>Dosage Form:</b> topical suspension<br/></p><ul class="nav-tabs nav-tabs-collapse nav-tabs-pill">
<li>Side Effects</li>
<li>Dosage</li>
<li><b class="nav-item here">Professional</b></li>
<li class="nav-more">
More&lt;html&gt;&lt;head&gt;&lt;/head&gt;&lt;body&gt;&lt;svg aria-hidden="true" class="ddc-icon ddc-icon-down" focusable="false" height="16" viewBox="0 0 24 24" width="16" xmlns="http://www.w3.org/2000/svg"&gt;&lt;path d="M18.5 7.94L19.56 9 12 16.56 4.44 9 5.5 7.94l6.5 6.5z"&gt;&lt;/path&gt;&lt;/svg&gt;&lt;/body&gt;&lt;/html&gt;
</li>
</ul><p class="disclaimer">Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.</p><ul>
<li>Description</li>
<li>Clinical Pharmacology</li>
<li>Indications and Usage</li>
<li>Contraindications</li>
<li>Warnings</li>
<li>Precautions</li>
<li>Adverse Reactions/Side Effects</li>
<li class="ddc-toggle-hidden">Dosage and Administration</li>
<li class="ddc-toggle-hidden">How Supplied/Storage and Handling</li>
</ul><p class="First"><span class="Bold">Rx Only</span></p><p>(50% Urea) In a lactic acid &amp; salicylic acid vehicle</p><p><span class="Bold">For external use only.<br/>
Not for ophthalmic use.</span></p><p>The Latrix brand name has been discontinued in the U.S. If generic versions of this product have been approved by the FDA, there may be generic equivalents available.</p><h2>Latrix Description</h2><p class="First">Each gram of Latrix™ Topical Suspension contains: ACTIVE: 50% Urea in a topical suspension base of INACTIVES: consisting of Caprylic/Capric Triglyceride, Carbomer, Cetyl Alcohol, Edetate Disodium, Glycerin, Hydroxyethylcellulose, Lactic Acid, Linoleic Acid, PEG-6, Polysorbate 60, Propylene Glycol, Purified Water, Salicylic Acid, Sorbitan Stearate, Titanium Dioxide, Trolamine, Vitamin E and Xanthan Gum.</p><p>Urea is a diamide of carbonic acid with the following chemical structure:</p><h2>Latrix - Clinical Pharmacology</h2><p class="First">Urea gently dissolves the intercellular matrix, which results in loosening the homy layer of skin and shedding scaly skin at regular intervals, thereby softening hyperkeratotic areas.</p><h3>PHARMACOKINETICS</h3><p class="First">The mechanism of action of topically applied Urea is not yet known.</p><h2>INDICATIONS AND USES</h2><p class="First">For debridement and promotion of normal healing of hyperkeratolic surface lesions, particularly where healing is retarded by local infection, necrotic tissues, fibrinour or purulent debris or eschar. Urea is useful for the treatment of hyperkeratotic conditions such as dry, rough skin, dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis pilaris, keratosis Palmaris, keratoderma, corns and calluses.</p><h2>Contraindications</h2><p class="First">Known hypersensitivity to any of the listed ingredients.</p><h2>Warnings</h2><p class="First">For external use only. Avoid contact with eyes, lips or mucous membranes.</p><h2>Precautions</h2><p class="First">This medication is to be used as directed by a physician and should not be used to treat any condition other then that for which it was prescribed. If redness or irritation occurs, discontinue use.</p><h3>PREGNANCY</h3><p class="First">Animal reproduction studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, Latrix™ Topical Suspension should be given to a pregnant woman only if clearly needed.</p><h3>NURSING MOTHERS</h3><p class="First">It is not known whether or not this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Latrix™ Topical Suspension is administered to a nursing woman.</p><p class="First"><span class="Bold">Keep this and all other medications out of reach of children.</span></p><h2>Adverse Reactions</h2><p class="First">Transient stinging, burning, itching or irritation may occur and normally disappear on discontinuing the medication.</p><h2>Latrix Dosage and Administration</h2><p class="First">Apply Latrix™ Topical Suspension to the affected skin twice per day, or as directed by a physician. Rub in until completely absorbed.</p><h2>How is Latrix Supplied</h2><p class="First">Latrix™ Topical Suspension (50% Urea) is supplied as:</p><p class="First">Store at controlled room temperature 15°-30° C (59°-86° F.) Protect from freezing.</p><p class="First"><span class="Italics">Distributed by:</span><br/>
STRATUS PHARMACEUTICALS INC<br/>
14377 SW 142ND Street, Miami, Florida 33186</p><p>LTS-JG 2008-03</p><h2>PRINCIPAL DISPLAY PANEL - 284 g Carton</h2><p class="First"><span class="Bold">NDC 58980-777-10</span></p><p>Rx Only</p><p><span class="Bold">Latrix™</span><br/>
TOPICAL SUSPENSION</p><p>(50% Urea)<br/>
In a lactic acid &amp;<br/>
salicylic acid vehicle</p><p>For Topical Use Only</p><p><span class="Bold">STRATUS</span><br/>
PHARMACEUTICALS INC</p><p><span class="Bold">Net Wt. 10 oz (284 g)</span></p><h2>More about Latrix (urea topical)</h2><ul class="more-resources-list more-resources-list-general">
<li>Side Effects</li>
<li>Dosage Information</li>
<li>Drug class: topical emollients</li>
</ul><h3>Consumer resources</h3><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Dermatological Disorders</li>
<li>Dry Skin</li>
<li>Pityriasis rubra pilaris</li>
</ul><p class="ddc-disclaimer-link">Medical Disclaimer</p></body></html>